- Home
- VYNE vs SPHL Comparison
VYNE vs SPHL Comparison
Compare VYNE & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- SPHL
- Stock Information
- Founded
- VYNE 2003
- SPHL 2002
- Country
- VYNE United States
- SPHL Singapore
- Employees
- VYNE N/A
- SPHL N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- SPHL Homebuilding
- Sector
- VYNE Health Care
- SPHL Consumer Discretionary
- Exchange
- VYNE Nasdaq
- SPHL Nasdaq
- Market Cap
- VYNE 12.3M
- SPHL 10.0M
- IPO Year
- VYNE 2018
- SPHL 2024
- Fundamental
- Price
- VYNE $0.38
- SPHL $0.43
- Analyst Decision
- VYNE Buy
- SPHL
- Analyst Count
- VYNE 2
- SPHL 0
- Target Price
- VYNE $8.00
- SPHL N/A
- AVG Volume (30 Days)
- VYNE 1.7M
- SPHL 973.6K
- Earning Date
- VYNE 11-06-2025
- SPHL 12-29-2025
- Dividend Yield
- VYNE N/A
- SPHL N/A
- EPS Growth
- VYNE N/A
- SPHL N/A
- EPS
- VYNE N/A
- SPHL N/A
- Revenue
- VYNE $524,000.00
- SPHL $5,956,226.00
- Revenue This Year
- VYNE N/A
- SPHL N/A
- Revenue Next Year
- VYNE N/A
- SPHL N/A
- P/E Ratio
- VYNE N/A
- SPHL N/A
- Revenue Growth
- VYNE 6.29
- SPHL N/A
- 52 Week Low
- VYNE $0.28
- SPHL $0.35
- 52 Week High
- VYNE $4.30
- SPHL $7.80
- Technical
- Relative Strength Index (RSI)
- VYNE 55.03
- SPHL 41.99
- Support Level
- VYNE $0.35
- SPHL $0.40
- Resistance Level
- VYNE $0.40
- SPHL $0.46
- Average True Range (ATR)
- VYNE 0.03
- SPHL 0.12
- MACD
- VYNE 0.00
- SPHL -0.01
- Stochastic Oscillator
- VYNE 74.75
- SPHL 11.41
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.